PTEN: Multiple Functions in Human Malignant Tumors
Michèle Milella(National Cancer Institute), Ludovica Ciuffreda(National Cancer Institute)
Cited by 460
Related Papers
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2012|5.5k
MEK blockade converts AML differentiating response to retinoids into extensive apoptosis
|Blood|2006|42
Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors
|Cancers|2019|31
BRAF status modulates Interelukin-8 expression through a CHOP-dependent mechanism in colorectal cancer
|Communications Biology|2020|18
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy
|Therapeutic Advances in Medical Oncology|2023|11